Endonovo Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2011 | — | $0 | $9.4K |
| FY2012 | — | $-1.9M | $800 |
| FY2013 | — | $-4.1M | $3.3K |
| FY2014 | $1.6M | $-4.7M | $988 |
| FY2015 | $28.6K | $-9.3M | $41.5K |
| FY2016 | $3.2M | $-8.6M | $55.5K |
| FY2017 | $7.4M | $-9.6M | $90.2K |
| FY2018 | $8.2M | $-11.4M | $379.2K |
| FY2019 | $6.9M | $-20.5M | $18.9K |
| FY2020 | $6.8M | $-14.4M | $13.4K |
| FY2021 | $7.3M | $-15.8M | $85.9K |
| FY2022 | $7.2M | $-32.2M | — |